83 related articles for article (PubMed ID: 3834819)
1. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
Giraud-Serio J; Goyot C; Debray Q; Plaisant O; Grenier J; Pélicier Y
Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
[No Abstract] [Full Text] [Related]
2. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients.
Aschauer HN; Schönbeck G; Langer G; Koinig G; Resch F; Hatzinger R; Chaudry HR; Sieghart W
Pharmacopsychiatry; 1988 Sep; 21(5):246-51. PubMed ID: 3227055
[TBL] [Abstract][Full Text] [Related]
3. Correlates of early neuroleptic response using a uniform haloperidol dose.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N
Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
[TBL] [Abstract][Full Text] [Related]
4. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
[TBL] [Abstract][Full Text] [Related]
5. Plasma catecholamine metabolites and early response to haloperidol.
Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
[TBL] [Abstract][Full Text] [Related]
6. Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis.
Swigar ME; Jatlow PI; Goicoechea N; Opsahl C; Bowers MB
Am J Psychiatry; 1984 Oct; 141(10):1281-3. PubMed ID: 6486269
[TBL] [Abstract][Full Text] [Related]
7. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R
Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339
[No Abstract] [Full Text] [Related]
8. Serum haloperidol concentrations and clinical response in acute psychosis.
Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
[TBL] [Abstract][Full Text] [Related]
9. A gas chromatographic mass spectrometric chemical ionization assay for haloperidol with selected ion monitoring.
Hornbeck CL; Griffiths JC; Neborsky RJ; Faulkner MA
Biomed Mass Spectrom; 1979 Oct; 6(10):427-30. PubMed ID: 526559
[TBL] [Abstract][Full Text] [Related]
10. Plasma haloperidol levels and clinical response: confounding variables.
Mavroidis ML; Garver DL; Kanter DR; Hirschowitz J
Psychopharmacol Bull; 1985; 21(1):62-5. PubMed ID: 3983340
[No Abstract] [Full Text] [Related]
11. Influence of route of administration on haloperidol plasma levels in psychotic patients.
Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P
Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678
[TBL] [Abstract][Full Text] [Related]
12. [Use of very high doses of haloperidol in the treatment of acute psychotic episodes. Clinical and pharmacokinetic analysis apropos of 15 cases].
Petit P; Blayac JP; Castelnau D; Billet J; Puech R; Pouget R
Encephale; 1987; 13(3):127-30. PubMed ID: 3595515
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
Parent M; Toussaint C; Driesens F; Gelders Y
Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
[No Abstract] [Full Text] [Related]
14. Clinical efficacy of haloperidol in chronic psychotic patients.
Lapolla A
Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
[No Abstract] [Full Text] [Related]
15. Haloperidol plasma/red blood cell ratios and clinical efficacy.
Neborsky R; Janowsky DS; Perel J; Munson E; Depry D
Psychopharmacol Bull; 1982 Oct; 18(4):17-20. PubMed ID: 7156285
[No Abstract] [Full Text] [Related]
16. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
[TBL] [Abstract][Full Text] [Related]
17. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
[TBL] [Abstract][Full Text] [Related]
18. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
[TBL] [Abstract][Full Text] [Related]
19. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients.
Lee BH; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):658-62. PubMed ID: 16466670
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in plasma homovanillic acid in acute psychosis.
Bowers MB; Swigar ME; Jatlow PI
N Engl J Med; 1983 Apr; 308(14):845-6. PubMed ID: 6835278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
